Persistence and failure rates of adalimumab monotherapy in biologic-naïve patients with psoriasis: A retrospective study
J Am Acad Dermatol
.
2016 Mar;74(3):575-7.
doi: 10.1016/j.jaad.2015.11.005.
Authors
Shivani P Reddy
1
,
Elaine J Lin
2
,
Vidhi V Shah
3
,
Jashin J Wu
4
Affiliations
1
University of Illinois at Chicago College of Medicine.
2
Loma Linda University School of Medicine, Los Angeles, California.
3
University of Missouri-Kansas City School of Medicine.
4
Department of Dermatology, Kaiser Permanente Los Angeles Medical Center. Electronic address: jashinwu@hotmail.com.
PMID:
26892660
DOI:
10.1016/j.jaad.2015.11.005
No abstract available
Publication types
Letter
MeSH terms
Adalimumab / administration & dosage*
Anti-Inflammatory Agents / administration & dosage*
Humans
Psoriasis / drug therapy*
Retrospective Studies
Treatment Failure
Substances
Anti-Inflammatory Agents
Adalimumab